NVDA
NVIDIA
-- 140.200 TSLA
Tesla
-- 395.600 RGTI
Rigetti Computing
-- 9.5725 PLTR
Palantir
-- 67.785 AMD
Advanced Micro Devices
-- 122.540 
$Pfizer (PFE.US)$ Moderna stock jumped early Tuesday after t...
Moderna stock jumped early Tuesday after the first bird flu death was reported in the U.S.
Shares were up 3.8% to $44.23 in premarket trading, after initially rising as much as 6%. Futures tracking the benchmark S&P 500 index traded largely flat.
Moderna is one of a few drugmakers currently developing a vaccine for the H5N1 bird flu, which is spreading rapidly through farms and wild animals in North America.
As of Jan. 6, there have been 66 confirmed human cases of H5N1 bird flu in the U.S. since 2024 and 67 since 2022, according to the Centers for Disease Control and Prevention.
Pfizer and GSK in partnership with CureVac are also developing mRNA vaccines for bird flu.
Pfizer stock was up 0.5% in premarket trading Tuesday, after rising 1.1% Monday. GSK's American depositary receipts, or ADRs, were down 0.2%.
CureVac, a Germany-based biotech with a market cap of just under $1 billion, rose almost 9% in the premarket after a 23% gain Monday.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
Deep Sea OP : Expect another new upcoming pandemic this year. I will see u at $50 finishing line.
Deep Sea OP : PPE stocks will rise too.
101784548 : Pandemic?
Deep Sea OP 101784548 : Not yet. But upcoming soon since one person died from H5N1.